Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L36 pseudogene 16 (RPL36P16) is a processed pseudogene related to the ribosomal protein L36 gene. While the functional RPL36 gene encodes a component of the large 60S ribosomal subunit essential for protein synthesis, RPL36P16 itself does not encode a protein and has no documented biological function or association with therapeutic intervention[1][3][5][6]. Pseudogenes like RPL36P16 are common for ribosomal protein genes, arising from genomic duplication or retrotransposition events during evolution, and are typically nonfunctional genetic elements dispersed throughout the genome[1][3]. RPL36P16 should not be confused with the true protein-coding gene RPL36 (Ribosomal protein L36), which is a component of the ribosome and functionally relevant for protein synthesis[1][3][6]. Users searching for "RPL36P16" in the context of drug targets, molecular mechanisms, or biomarkers should be aware that this pseudogene has no current utility or role in these areas[5]. For structured databases, it should be clearly classified as a non-target, non-functional pseudogene entry[5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36 pseudogene 16 (RPL36P16).